Gatifloxacin
ZYMAXID ® is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic gram-positive bacteria: Staphylococcus aureus Staphylococcus epidermidis Streptococcus mitis group * Streptococcus oralis * Streptococcus pneumoniae Aerobic gram-neg…
United States
$465
per month
India
$36
per month
You save
−92%save $429/mo · 92% cheaper
29.2K US scripts/yr$12.5M potential annual savings$13.6M US spend/yr
Drag to rotate · 3D structureC19H22FN3O4
SMILES: CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
Compare the price
US price$465per month
India price$36per month
You save$42992% less
Based on 30 units per month. US $15.50 vs India $1.20 per unit.
Total over 1 periodSave $429$465 → $36
The bigger picture
Gatifloxacin is filled about 29.2K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$13.6M
If sourced from India
$1.1M
Potential annual savings
$12.5M
−92%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.